Drugs Made In America Acquisition II Corp. (DMIIU) Income from Continuing Operations (2025)
Drugs Made In America Acquisition (DMIIU) posted quarterly Income from Continuing Operations of 4588973.0 for Q4 2025, up 10041.88% quarter-over-quarter from 46158.0 in Q3 2025.
Drugs Made In America Acquisition II Corp. (DMIIU) Income from Continuing Operations (2025) Analysis & Trends
Drugs Made In America Acquisition (DMIIU) has reported Income from Continuing Operations for 1 consecutive years, with 4588973.0 the latest figure, recorded in Q4 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.59 Mn |
| Sep 30, 2025 | -46,158.00 |